Lisata Therapeutics Inc (LSTA)

Currency in USD
2.5000
-0.0100(-0.40%)
Closed·
2.49000.0000(0.00%)
·
LSTA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
LSTA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.38002.5500
52 wk Range
1.87004.2000
Key Statistics
Prev. Close
2.5
Open
2.42
Day's Range
2.38-2.55
52 wk Range
1.87-4.2
Volume
15.28K
Average Volume (3m)
33.21K
1-Year Change
-15.54%
Book Value / Share
2.45
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LSTA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
20.6667
Upside
+726.67%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Lisata Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Lisata Therapeutics Inc Company Profile

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with a range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

Lisata Therapeutics Inc Earnings Call Summary for Q2/2025

  • Q2 2025 EPS beats forecast at -0.54 vs -0.64, with $70,000 revenue from Catalent license
  • Operating expenses down 10.6% YoY; $22M cash reserves to support operations into 2026
  • Advancing certepatide in multiple cancer trials; Phase III for pancreatic cancer planned
  • Stock fell 5.41% despite earnings beat; company maintains strong liquidity position
  • CEO highlights certepatide's broad applicability; new patent secured until March 2040
Last Updated: 08/08/2025, 11:04
Read Full Transcript

Compare LSTA to Peers and Sector

Metrics to compare
LSTA
Peers
Sector
Relationship
P/E Ratio
−1.2x−0.6x−0.6x
PEG Ratio
−0.09−0.020.00
Price/Book
1.0x0.9x2.6x
Price / LTM Sales
20.5x8.8x3.3x
Upside (Analyst Target)
-297.1%40.1%
Fair Value Upside
Unlock15.9%5.3%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 20.6667
(+726.67% Upside)

Earnings

Latest Release
Aug 07, 2025
EPS / Forecast
-0.54 / -0.64
Revenue / Forecast
70.00K / --
EPS Revisions
Last 90 days

LSTA Income Statement

People Also Watch

2.40
INMB
-5.14%
3.7000
SNGX
-25.40%
3.970
ATAI
-1.98%
2.570
ACHV
-3.38%
0.333
VYNE
-3.20%

FAQ

What Stock Exchange Does Lisata Therapeutics Trade On?

Lisata Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Lisata Therapeutics?

The stock symbol for Lisata Therapeutics is "LSTA."

What Is the Lisata Therapeutics Market Cap?

As of today, Lisata Therapeutics market cap is 21.71M.

What Is Lisata Therapeutics's Earnings Per Share (TTM)?

The Lisata Therapeutics EPS (TTM) is -2.23.

When Is the Next Lisata Therapeutics Earnings Date?

Lisata Therapeutics will release its next earnings report on 05 Nov 2025.

From a Technical Analysis Perspective, Is LSTA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Lisata Therapeutics Stock Split?

Lisata Therapeutics has split 6 times.

How Many Employees Does Lisata Therapeutics Have?

Lisata Therapeutics has 26 employees.

What is the current trading status of Lisata Therapeutics (LSTA)?

As of 20 Aug 2025, Lisata Therapeutics (LSTA) is trading at a price of 2.50, with a previous close of 2.50. The stock has fluctuated within a day range of 2.38 to 2.55, while its 52-week range spans from 1.87 to 4.20.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.